Skip to main content
European Commission logo
Enterprise Europe Network

Turkish Institution (Excellence Center) is Looking for a Partner from Europe for the MSCA-Call – Networking for know-how transfer in the development of microneedle-based biomedical technologies and products


Profile Type
Research & Development Request
POD Reference
Term of Validity
6 December 2023 - 5 December 2024
Company's Country
Type of partnership
Research and development cooperation agreement
Targeted Countries
All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
The aim of the project is to enhance knowledge transfer of new technologies and techniques in the production of microneedle-based therapeutic systems, tissue grafts and networking for collective innovative solution development. This initiative focuses on enhancing the cross-cutting interactions of academics and non-academic professionals skilled in microneedle-based technologies to develop novel biomedical products and tools with excellence in knowledge and know-how.
Full Description
The applications of micro-needle-based platforms developed using the DLP method, which enables the development of layered and well-designed approaches, have attracted attention in current studies as a solution for diverse tissue damage, such as drug delivery and therapeutic systems. DLP has great potential especially for the development of scaffolds and drug delivery platforms with well-tuned composition and topology that can adapt to the environment of body. Modular modifications of microneedles with distinct biomolecules, their use in combination with nanoparticles and drug loading approaches become prominent for the development of advanced approaches in tissue repair mechanisms.
Project proposers specialized in materials and biomaterials have been focusing on 3D printing, microneedle-based approaches for the last 5 years. In addition to being practitioners in this field, they also aim to network with industry and academia on various topics such as the development of modular printing strategies and the integration of nanotechnological carrier systems into microneedle-based tissue engineering products. In this context, the aim of the project proposal is to share know-how in research and development and industrial product development and to enable the production of scaffold and drug delivery platform that can be used for various biomedical applications.
Advantages and Innovations
In this study, networking between partners with diverse expertise is aimed to achieve modular and functionalized approaches in the production of microneedles manufactured by DLP, which is a remarkable method for the production of well-tuned scaffold and drug delivery platform. In this proposal, which aims to enable academic and non-academic collaboration, the knowledge of the partners will be enriched by cross interaction and thus product development strategies will be strengthened.
Stage of Development
Concept stage
Sustainable Development Goals
Goal 3: Good Health and Well-beingGoal 9: Industry, Innovation and InfrastructureGoal 8: Decent Work and Economic Growth

Partner Sought

Expected Role of a Partner
Within the project's framework, there is a specific requirement to enhance collaborations with SMEs. Consequently, SMEs specialized in biomaterials, tissue engineering and drug delivery systems, and more specifically in 3D printing applications, tissue grafting and carrier systems such as exosomes, noisomes and liposomes, or modification of microneedles with bioactive molecules such as peptides (which can also be integrated with carrier systems) are sought. Potential partners are welcome from any location in Europe, and active engagement in open science networking activities is strongly encouraged without any restrictions.
Type and Size of Partner
SME 11-49SME <=10SME 50 - 249Big company
Type of partnership
Research and development cooperation agreement

Call details

Framework program
Horizon Europe
Call title and identifier
MSCA Staff Exchanges 2023: HORIZON-MSCA-2023-SE-01-01
Submission and evaluation scheme
Coordinator required
Deadline for EoI
Deadline of the call
IPR description
3D printing, DLP, microneedle, scaffold, drug delivery, biomedical applications, and tissue grafts


Technology keywords
06005003 - Health information management006001002 - Care and Health Services01004001 - Applications for Health
Market keywords
05007007 - Other medical/health related (not elsewhere classified)02007012 - Medical/health software
Sector Groups Involved
Targeted countries
All countries